"We are united in our enthusiasm for Masimo’s future as a leading, innovation-focused growth company," the newest board ...
Shares of Masimo have risen since the news of a court ruling against Politan. The ruling is likely to favor MASI's founder in ...
Masimo (MASI – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Vik Chopra from ...
Activist investor Politan Capital said it won two seats on the board of the $6bn medical device company Masimo on Thursday, ...
Politan Capital Management (together with its affiliates, "Politan"), an 8.9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ: MASI), today issued an open letter to shareholders ...
Masimo Corp (MASI) stock saw a modest uptick, ending the day at $114.99 which represents a slight increase of $3.63 or 3.26% from the prior close of $111.36. The stock opened at $111.17 and touched a ...
that a takeover by Politan and Quentin Koffey would destroy Masimo’s innovation engine, credibility, growth and stock price. The September 19, 2024 Annual Meeting is fast approaching ...
Founder Joe Kiani has led Masimo for 35 years. But he says he'll quit if he loses this week's proxy vote to Politan Capital.